Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Xbrane Biopharma

    Client Virtual Booth

    XBRANE BIOPHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Xbrane Biopharma
    Sweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Banvaktsvägen 22 171 48 Solna Sweden
    Telephone
    Telephone
    +46 76-034 67 33
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://xbrane.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/1630164?trk=tyah&trkInfo=clickedVertical:company,clickedEntityId:1630164,idx:1-1-1,tarId:1477399504590,tas:xbrane
    Twitter
    Twitter
    https://twitter.com/XbraneBiopharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Stada and Xbrane gain EU approval for biosimilar Ximluci
    Stada and Xbrane gain EU approval for biosimilar Ximluci

    https://www.pharmatimes.com/news/stada_and_xbrane_gain_eu_approval_for_biosimilar_ximluci_1480676

    PHARMATIMES
    11 Nov 2022
    Share Share
    STADA and Xbrane welcome EMA positive opinion for ranibizumab biosimilar
    STADA and Xbrane welcome EMA positive opinion for ranibizumab biosimilar

    https://www.stada.com/blog/posts/2022/september/stada-and-xbrane-welcome-ema-positive-opinion-for-ranibizumab-biosimilar-candidate-ximluci

    STADA
    16 Sep 2022
    Share Share
    Russia Launches Omalizumab; Remsima Sales Soar; Xbrane Trial Results
    Russia Launches Omalizumab; Remsima Sales Soar; Xbrane Trial Results

    https://www.centerforbiosimilars.com/view/biosimilar-business-news-roundup-russia-launches-omalizumab-remsima-sales-soar-xbrane-trial-results

    CENTERFORBIOSIMILARS
    19 Feb 2022
    Share Share
    Biogen and Xbrane Announce Commercialization and License Agreement for CIMZIA
    Biogen and Xbrane Announce Commercialization and License Agreement for CIMZIA

    https://www.globenewswire.com/news-release/2022/02/07/2380345/0/en/Biogen-and-Xbrane-Announce-Commercialization-and-License-Agreement-for-Proposed-Biosimilar-Referencing-CIMZIA-Certolizumab-pegol-with-the-Potential-to-Treat-Rheumatoid-Arthritis.html

    GLOBENEWSWIRE
    07 Feb 2022
    Share Share
    Xbrane has initiated development of two new biosimilar candidates
    Xbrane has initiated development of two new biosimilar candidates

    https://xbrane.com/en/mfn_news_en/xbrane-has-initiated-development-of-two-new-biosimilar-candidates-building-an-oncology-biosimilar-portfolio-targeting-e23-billion-in-annual-reference-product-sales/

    PRESS RELEASE
    13 Dec 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search